Abiopharma

🔍 Bulgarelli Peter J. (Executive)

Company: Ventas, Inc. (VTR)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 2,346 shares of Common Stock at $88.02 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 124,422.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,372 shares of Common Stock at $88.02 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 122,050.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 1,496 shares of Common Stock at $88.02 per share (Direct)
  Date: 2026-05-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 120,554.00 | transaction_form_type: 4 | Footnotes: F4, F2

Footnotes:

• F1: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on January 2, 2024 under the Ventas, Inc. 2022 Incentive Plan, in connection with the Reporting Person's retirement effective May 1, 2026.
• F2: Represents the applicable closing price per share of Issuer's common stock as of the date of the vesting.
• F3: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on January 2, 2025 under the Ventas, Inc. 2022 Incentive Plan, in connection with the Reporting Person's retirement effective May 1, 2026.
• F4: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on February 11, 2026 under the Ventas, Inc. 2022 Incentive Plan, in connection with the Reporting Person's retirement effective May 1, 2026.